Reported Earnings • Mar 14
Full year 2025 earnings released: NT$1.53 loss per share (vs NT$1.01 loss in FY 2024) Full year 2025 results: NT$1.53 loss per share (further deteriorated from NT$1.01 loss in FY 2024). Revenue: NT$1.51b (up 7.2% from FY 2024). Net loss: NT$104.2m (loss widened 52% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Announcement • Mar 13
MetaTech (AP) Inc., Annual General Meeting, Jun 26, 2026 MetaTech (AP) Inc., Annual General Meeting, Jun 26, 2026. Location: b2 floor no,176, sec.1 chi lung rd., sinyi district, taipei city Taiwan Reported Earnings • Nov 13
Third quarter 2025 earnings released: NT$0.24 loss per share (vs NT$0.18 loss in 3Q 2024) Third quarter 2025 results: NT$0.24 loss per share (further deteriorated from NT$0.18 loss in 3Q 2024). Revenue: NT$390.9m (down 5.6% from 3Q 2024). Net loss: NT$16.1m (loss widened 35% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 36% per year but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Reported Earnings • Aug 17
Second quarter 2025 earnings released: NT$0.62 loss per share (vs NT$0.14 loss in 2Q 2024) Second quarter 2025 results: NT$0.62 loss per share (further deteriorated from NT$0.14 loss in 2Q 2024). Revenue: NT$371.5m (up 12% from 2Q 2024). Net loss: NT$42.2m (loss widened 327% from 2Q 2024). Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings. Reported Earnings • May 18
First quarter 2025 earnings released: NT$0.20 loss per share (vs NT$0.37 loss in 1Q 2024) First quarter 2025 results: NT$0.20 loss per share (improved from NT$0.37 loss in 1Q 2024). Revenue: NT$387.3m (up 17% from 1Q 2024). Net loss: NT$13.5m (loss narrowed 47% from 1Q 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Announcement • May 01
MetaTech (AP) Inc. to Report Q1, 2025 Results on May 08, 2025 MetaTech (AP) Inc. announced that they will report Q1, 2025 results on May 08, 2025 Announcement • Mar 12
MetaTech (AP) Inc., Annual General Meeting, Jun 24, 2025 MetaTech (AP) Inc., Annual General Meeting, Jun 24, 2025. Location: 1 floor no,152, sec.1 ta t`ung rd., sijhih district, new taipei city Taiwan Announcement • Mar 04
MetaTech (AP) Inc. to Report Fiscal Year 2024 Results on Mar 11, 2025 MetaTech (AP) Inc. announced that they will report fiscal year 2024 results on Mar 11, 2025 New Risk • Feb 20
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.24b (US$99.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.9% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$3.24b market cap, or US$99.0m). New Risk • Dec 30
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.25b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.9% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$3.25b market cap, or US$99.2m). New Risk • Nov 18
New major risk - Revenue and earnings growth Earnings have declined by 6.9% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • Nov 18
Third quarter 2024 earnings released: NT$0.18 loss per share (vs NT$0.003 loss in 3Q 2023) Third quarter 2024 results: NT$0.18 loss per share (further deteriorated from NT$0.003 loss in 3Q 2023). Revenue: NT$413.9m (up 9.5% from 3Q 2023). Net loss: NT$12.0m (loss widened NT$11.8m from 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 70 percentage points per year, which is a significant difference in performance. Announcement • Nov 14
MetaTech Inc. Unveils its iPSC Family Stem Cell Storage Service MetaTech Inc. unveiled its "iPSC Family Stem Cell Storage" service. The launch event, held in Taipei, was graced by renowned Taiwanese pop icon Jay Chou's wife, Hannah Quinlivan, who serves as the service's ambassador. Quinlivan has not only donated her own peripheral blood but has also entrusted her daughter's umbilical cord blood to MetaTech for the creation and storage of iPSC (induced pluripotent stem cell). Supported by the Taiwan government's National Science and Technology Council, the Academia Sinica launched a customized iPSC pluripotent stem cell service in 2015, laying the foundation for the nation's regenerative medicine industry. With the recent passage of Taiwan's Regenerative Medicine Act and MetaTech's subsidiary, Locus Cell Technology Co. Ltd., securing a global commercial license from Japan's iPSC Academia Japan Inc., MetaTech is now poised to lead the way in the region's iPSC family stem cell storage market. Announcement • Nov 05
MetaTech (AP) Inc. to Report Q3, 2024 Results on Nov 12, 2024 MetaTech (AP) Inc. announced that they will report Q3, 2024 results on Nov 12, 2024 New Risk • Nov 01
New minor risk - Market cap size The company's market capitalization is less than US$100m. Market cap: NT$3.19b (US$100.0m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. This is currently the only risk that has been identified for the company. Reported Earnings • Aug 17
Second quarter 2024 earnings released: NT$0.15 loss per share (vs NT$0.019 profit in 2Q 2023) Second quarter 2024 results: NT$0.15 loss per share (down from NT$0.019 profit in 2Q 2023). Revenue: NT$332.5m (down 17% from 2Q 2023). Net loss: NT$9.90m (down NT$11.2m from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Announcement • Aug 07
MetaTech (AP) Inc. to Report Q2, 2024 Results on Aug 13, 2024 MetaTech (AP) Inc. announced that they will report Q2, 2024 results on Aug 13, 2024 New Risk • May 29
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (6.6% average weekly change). Market cap is less than US$100m (NT$3.20b market cap, or US$98.7m). Reported Earnings • May 19
First quarter 2024 earnings released: NT$0.37 loss per share (vs NT$0.37 loss in 1Q 2023) First quarter 2024 results: NT$0.37 loss per share (improved from NT$0.37 loss in 1Q 2023). Revenue: NT$330.1m (down 12% from 1Q 2023). Net loss: NT$25.3m (flat on 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 27% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Announcement • May 15
MetaTech (AP) Inc. announced a financing transaction MetaTech (AP) Inc. announced a private placement to issue not more than 10,000,000 common shares on May 13, 2024. The transaction has been approved by shareholders of the company. Announcement • May 05
MetaTech (AP) Inc. to Report Q1, 2024 Results on May 13, 2024 MetaTech (AP) Inc. announced that they will report Q1, 2024 results on May 13, 2024 Announcement • Apr 10
MetaTech (AP) Inc., Annual General Meeting, Jun 27, 2024 MetaTech (AP) Inc., Annual General Meeting, Jun 27, 2024. Reported Earnings • Apr 02
Full year 2023 earnings released: NT$1.94 loss per share (vs NT$0.17 loss in FY 2022) Full year 2023 results: NT$1.94 loss per share (further deteriorated from NT$0.17 loss in FY 2022). Revenue: NT$1.45b (down 22% from FY 2022). Net loss: NT$131.9m (loss widened NT$120.2m from FY 2022). Over the last 3 years on average, earnings per share has increased by 7% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 14
Third quarter 2023 earnings released: NT$0.003 loss per share (vs NT$0.16 loss in 3Q 2022) Third quarter 2023 results: NT$0.003 loss per share (improved from NT$0.16 loss in 3Q 2022). Revenue: NT$378.2m (down 8.7% from 3Q 2022). Net loss: NT$196.0k (loss narrowed 98% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 44% per year but the company’s share price has fallen by 2% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 12
Second quarter 2023 earnings released: EPS: NT$0.02 (vs NT$0.024 in 2Q 2022) Second quarter 2023 results: EPS: NT$0.02 (down from NT$0.024 in 2Q 2022). Revenue: NT$401.6m (down 21% from 2Q 2022). Net income: NT$1.27m (down 23% from 2Q 2022). Profit margin: 0.3% (in line with 2Q 2022). Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Announcement • May 17
MetaTech (AP) Inc.,CHUN-LUNGWU and AlexCHEN agreed to acquire 12.69% stake in Up Cell Biomedical Co. from CellSeed Inc. (TSE:7776). MetaTech (AP) Inc.,CHUN-LUNGWU and AlexCHEN agreed to acquire 12.69% stake in Up Cell Biomedical Co. from CellSeed Inc. (TSE:7776) on May 15, 2023. Transfer execution date is June to late July 2023. Reported Earnings • Nov 19
Third quarter 2022 earnings released: NT$0.16 loss per share (vs NT$0.035 profit in 3Q 2021) Third quarter 2022 results: NT$0.16 loss per share (down from NT$0.035 profit in 3Q 2021). Revenue: NT$414.1m (down 28% from 3Q 2021). Net loss: NT$10.7m (down NT$12.8m from profit in 3Q 2021). Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Board Change • Nov 16
Less than half of directors are independent There are 8 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 8 new directors. 2 experienced directors. No highly experienced directors. 3 independent directors (7 non-independent directors). Independent Director Wen Chu Wang is the most experienced director on the board, commencing their role in 2015. Independent Director Shih-chie Yang was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Lack of experienced directors. Reported Earnings • Aug 16
Second quarter 2022 earnings released: EPS: NT$0.02 (vs NT$0.37 loss in 2Q 2021) Second quarter 2022 results: EPS: NT$0.02 (up from NT$0.37 loss in 2Q 2021). Revenue: NT$508.3m (up 26% from 2Q 2021). Net income: NT$1.64m (up NT$23.1m from 2Q 2021). Profit margin: 0.3% (up from net loss in 2Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 52% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings. Reported Earnings • May 16
First quarter 2022 earnings released: EPS: NT$0.25 (vs NT$0.17 loss in 1Q 2021) First quarter 2022 results: EPS: NT$0.25 (up from NT$0.17 loss in 1Q 2021). Revenue: NT$579.4m (up 44% from 1Q 2021). Net income: NT$17.1m (up NT$26.8m from 1Q 2021). Profit margin: 2.9% (up from net loss in 1Q 2021). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Board Change • Apr 27
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 8 experienced directors. 2 highly experienced directors. 3 independent directors (8 non-independent directors). Independent Director Rong Yi Wu was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Mar 31
Full year 2021 earnings released: NT$0.40 loss per share (vs NT$1.42 loss in FY 2020) Full year 2021 results: NT$0.40 loss per share (up from NT$1.42 loss in FY 2020). Revenue: NT$2.01b (up 28% from FY 2020). Net loss: NT$24.1m (loss narrowed 71% from FY 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings. Reported Earnings • Nov 15
Third quarter 2021 earnings released: EPS NT$0.04 (vs NT$0.30 loss in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: NT$575.9m (up 51% from 3Q 2020). Net income: NT$2.03m (up NT$19.6m from 3Q 2020). Profit margin: 0.4% (up from net loss in 3Q 2020). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 6% per year. Reported Earnings • Aug 18
Second quarter 2021 earnings released: NT$0.37 loss per share (vs NT$0.22 loss in 2Q 2020) The company reported a poor second quarter result with increased losses, weaker revenues and weaker control over costs. Second quarter 2021 results: Revenue: NT$405.0m (down 13% from 2Q 2020). Net loss: NT$21.4m (loss widened 66% from 2Q 2020). Over the last 3 years on average, earnings per share has fallen by 20% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Reported Earnings • May 18
First quarter 2021 earnings released: NT$0.17 loss per share (vs NT$0.43 loss in 1Q 2020) The company reported a solid first quarter result with reduced losses and improved control over expenses, although revenues were flat. First quarter 2021 results: Revenue: NT$403.8m (flat on 1Q 2020). Net loss: NT$9.75m (loss narrowed 61% from 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings. Reported Earnings • Mar 31
Full year 2020 earnings released: NT$1.42 loss per share (vs NT$1.60 loss in FY 2019) The company reported a solid full year result with reduced losses, improved revenues and improved control over expenses. Full year 2020 results: Revenue: NT$1.58b (up 12% from FY 2019). Net loss: NT$82.5m (loss narrowed 11% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Feb 18
New 90-day low: NT$41.55 The company is down 16% from its price of NT$49.60 on 20 November 2020. The Taiwanese market is up 18% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 22% over the same period. Is New 90 Day High Low • Jan 27
New 90-day low: NT$43.20 The company is down 14% from its price of NT$50.20 on 29 October 2020. The Taiwanese market is up 23% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 28% over the same period. Is New 90 Day High Low • Nov 25
New 90-day low: NT$46.60 The company is down 13% from its price of NT$53.70 on 27 August 2020. The Taiwanese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 5.0% over the same period. Reported Earnings • Nov 14
Third quarter 2020 earnings released: NT$0.30 loss per share The company reported a solid third quarter result with reduced losses and improved control over expenses, although revenues were flat. Third quarter 2020 results: Revenue: NT$382.0m (flat on 3Q 2019). Net loss: NT$17.5m (loss narrowed 32% from 3Q 2019). Over the last 3 years on average, earnings per share has fallen by 63% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Oct 12
New 90-day low: NT$47.60 The company is down 15% from its price of NT$56.30 on 14 July 2020. The Taiwanese market is up 4.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is down 3.0% over the same period. Is New 90 Day High Low • Sep 23
New 90-day low: NT$50.90 The company is down 5.0% from its price of NT$53.70 on 24 June 2020. The Taiwanese market is up 10.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 2.0% over the same period.